These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 93529)

  • 1. Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer.
    Ablin RJ; Bhatti RA; Guinan PD; Khin W
    Clin Exp Immunol; 1979 Oct; 38(1):83-91. PubMed ID: 93529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evaluation of the effect of estrogen on tumor-associated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Guinan PD
    Isr J Med Sci; 1979 Jan; 15(1):9-11. PubMed ID: 422345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate.
    Ablin RJ; Bhatti RA; Guinan PD
    Cancer Res; 1978 Nov; 38(11 Pt 1):3702-6. PubMed ID: 698929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effects of oestrogen on immunologic responsiveness. I. Inhibition of DNA synthesis in peripheral blood lymphocytes from patients with Peyronie's disease, prostatic cancer and transsexuals and a commentary.
    Ablin RJ; Bruns GR; Guinan PD; Al Sheik H; Bush IM
    Eur Urol; 1979; 5(6):359-68. PubMed ID: 467472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory effects of oestrogen in prostatic cancer: update and further consideration.
    Ablin RJ
    Allergol Immunopathol (Madr); 1981; 9(1):63-70. PubMed ID: 7258047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. II. Effect of oestrogen, cryosurgery and transurethral resection on thymic-dependent lymphocytic blastogenesis.
    Ablin RJ; Guinan PD; Bruns GR; Sheik HI; Sadoughi N; Bush IM
    Urol Int; 1976; 31(5):383-400. PubMed ID: 1087494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leuprolide vs. diethylstilboestrol: effect on natural killer cells.
    Ablin RJ; Gonder MJ; Bartkus JM
    Anticancer Res; 1988; 8(1):73-6. PubMed ID: 3128959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated immunity in prostatic cancer as evaluated by tube antigen-induced leukocyte adherence inhibition: reactivity and specificity of responsiveness, and relationship to stage, grade and therapy.
    Bhatti RA; Ablin RJ; Guinan PD
    J Reticuloendothel Soc; 1979 Apr; 25(4):389-95. PubMed ID: 458777
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-mediated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Nagubadi S; Zamora S; Guinan PD
    Clin Oncol; 1980 Sep; 6(3):253-64. PubMed ID: 7428203
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormonal therapy and alterations of immunity in prostatic cancer.
    Ablin RJ
    Neoplasma; 1981; 28(3):345-50. PubMed ID: 7290262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diethylstilboesterol diphosphate on tumour-assoiciated immunity in prostatic cancer. A preliminary report.
    Bhatti RA; Ablin RJ; Guinan PD; Totonchi E; Zamora S
    Experientia; 1978 Oct; 34(10):1364-5. PubMed ID: 738427
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormonal therapy and alteration of lymphocyte proliferation.
    Ablin RJ; Bruns GR; Guinan PD; Al sheik H; Bush IM
    J Lab Clin Med; 1976 Feb; 87(2):227-31. PubMed ID: 1245789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of human seminal plasma on tumour-associated immunity in patients with adenocarcinoma of the prostate.
    Ablin RJ; Bhatti RA; Bush IM; Guinan PD
    J Reprod Immunol; 1980 Feb; 1(5-6):337-45. PubMed ID: 7411523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible suppression of host resistance by estrogen therapy for prostatic cancer.
    Ablin RJ
    Can Med Assoc J; 1976 Dec; 115(11):1082-4. PubMed ID: 1000436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunotherapy of prostate and bladder cancer.
    Totterman TH; Loskog A; Essand M
    BJU Int; 2005 Oct; 96(5):728-35. PubMed ID: 16144528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular immunity in prostatic cancer modified by Cytonal, Estrazyt and Turisteron].
    Klebingat KJ; Panzig E; Lorenz G; Steinhauser I; Fiedler R
    Z Urol Nephrol; 1987 Mar; 80(3):139-47. PubMed ID: 3300097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients.
    Ohuchi H; Noguchi K; Kinoshita Y; Hosaka M; Kawasaki C; Miura T; Kondo I; Harada M
    Hinyokika Kiyo; 2000 Aug; 46(8):531-6. PubMed ID: 11019371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory effects of estrogen on immunologic responsiveness. III. Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in prostatic cancer.
    Ablin RJ
    Am J Reprod Immunol (1980); 1981 Aug; 1(4):206-9. PubMed ID: 7337156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary report of an immunological study in urological cancer.
    Serrallach N; Jimenez JF; Aguiló F; Anguera A; Clavo M; Orejas V; Torner V; Serrate R
    Eur Urol; 1975; 1(2):99-100. PubMed ID: 1241896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.